The organoid kit market size has grown rapidly in recent years. It will grow from $1.31 billion in 2025 to $1.52 billion in 2026 at a compound annual growth rate (CAGR) of 16.2%. The growth in the historic period can be attributed to advancements in stem cell research, increasing adoption in drug discovery, development of standardized kits, growth in biomedical research, rising funding for organoid studies.
The organoid kit market size is expected to see rapid growth in the next few years. It will grow to $2.75 billion in 2030 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to expansion in personalized medicine, integration of ai in organoid analysis, improvements in microfluidics platforms, growth of regenerative medicine applications, increased collaborations between pharma and biotech companies. Major trends in the forecast period include 3D cell culture advancements, personalized organoid development, microfluidics-based organoid platforms, organoid bioprinting technology, stem cell-derived disease modeling.
The rising prevalence of infectious diseases is anticipated to drive the expansion of the organoid kit market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, that can be transmitted directly or indirectly from one individual to another. The increase in infectious diseases is attributed to poor sanitation and overcrowding, which facilitate easier pathogen transmission and higher infection rates. Organoid kits contribute to combating infectious diseases by allowing researchers to model human tissues in laboratory settings, enabling detailed study of pathogen behavior, infection mechanisms, and the testing of potential treatments. For example, in August 2024, data released by the UK Health Security Agency (UKHSA), a UK-based executive agency, indicated that England recorded 368 measles cases in 2023, representing an almost sevenfold rise from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Consequently, the growing incidence of infectious diseases is fueling the expansion of the organoid kit market.
Companies in the organoid kit market are developing innovative solutions to improve consistency and scalability in organoid studies. One such innovation is rapid aggregate formation, which enables researchers to quickly generate thousands of uniform pluripotent stem cell aggregates in a single day, significantly reducing organoid development time. For instance, in June 2025, Pluristyx Inc., a US-based biotechnology company, introduced its PluriForm Organoid Kit, designed to streamline the creation of pluripotent stem cell aggregates and speed up organoid development. The kit offers a ready-to-use platform that shortens the timeline for generating mature organoids from months to just weeks. It integrates optimized growth media and standardized protocols, ensuring reproducibility across various cell types and supporting high-throughput applications for large-scale disease modeling and drug screening.
In April 2024, Sartorius AG, a Germany-based biotechnology company, formed a partnership with TheWell Bioscience Inc. to advance 3D cell culture and organoid research. This collaboration aims to enhance Sartorius AG’s 3D cell culture solutions by integrating TheWell Bioscience’s specialized hydrogel platforms, which are designed for use in organoid and spheroid research. TheWell Bioscience Inc., a US-based biotechnology company, specializes in 3D cell culture and organoid technology, leveraging advanced hydrogel platforms to support cellular modeling.
Major companies operating in the organoid kit market are STEMCELL Technologies Inc., Bio-Techne Corporation, Takara Bio Inc., American Type Culture Collection (ATCC), ACROBiosystems Inc., MIMETAS B.V., Emulate Inc., CN Bio Innovations Limited, InSCREENeX GmbH, TheWell Bioscience Inc., Prellis Biologics Inc., Crown Bioscience International, AMS Biotechnology (Europe) Limited (AMSBIO), Xylyx Bio Inc., Organovo Holdings Inc., HUB Organoids Holding B.V., Cellesce Ltd., DefiniGEN Ltd., OcellO B.V., AlveoliX AG, VitroLabs Inc.
North America was the largest region in the organoid kit market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organoid kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the organoid kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the organoid kit market by raising the costs of imported reagents, culture media, and laboratory instruments. Research institutes, pharmaceutical companies, and biotech firms in Europe and Asia-Pacific are most affected. Segments such as brain and liver organoid kits face higher import costs. Positive outcomes include boosting domestic production and fostering innovation in locally produced organoid kits, reducing long-term dependency on imports.
The organoid kit market research report is one of a series of new reports that provides organoid kit market statistics, including organoid kit industry global market size, regional shares, competitors with a organoid kit market share, detailed organoid kit market segments, market trends and opportunities, and any further data you may need to thrive in the organoid kit industry. This organoid kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Organoid kits are specialized laboratory toolsets designed to culture and grow miniaturized, three-dimensional organ-like structures from stem cells. These kits provide essential reagents, growth factors, and protocols to replicate organ development and function in vitro. They are widely applied in biomedical research, drug discovery, and disease modeling.
The primary types of organoid kits are brain organoids, kidney organoids, intestinal organoids, liver organoids, and others. Brain organoids are three-dimensional, miniaturized models of the human brain developed for research and therapeutic applications. Technologies used include 3D cell culture, microfluidics, bioprinting, and electrospinning. Source types include human-derived, animal-derived, and cell line-derived organoids. Applications span drug discovery and development, disease modeling, personalized medicine, regenerative medicine, and others. Key end users include research institutes, pharmaceutical companies, contract research organizations, and biotech companies.
The organoid kit market consists of revenues earned by entities by providing services such as organoid co-culture kits, organoid-on-a-chip integration services, and organoid toxicology testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The organoid kit market also includes sales of organoid biobanking kits, organoid functional assay kits, and organoid gene editing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The organoid kit market size is expected to see rapid growth in the next few years. It will grow to $2.75 billion in 2030 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to expansion in personalized medicine, integration of ai in organoid analysis, improvements in microfluidics platforms, growth of regenerative medicine applications, increased collaborations between pharma and biotech companies. Major trends in the forecast period include 3D cell culture advancements, personalized organoid development, microfluidics-based organoid platforms, organoid bioprinting technology, stem cell-derived disease modeling.
The rising prevalence of infectious diseases is anticipated to drive the expansion of the organoid kit market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, that can be transmitted directly or indirectly from one individual to another. The increase in infectious diseases is attributed to poor sanitation and overcrowding, which facilitate easier pathogen transmission and higher infection rates. Organoid kits contribute to combating infectious diseases by allowing researchers to model human tissues in laboratory settings, enabling detailed study of pathogen behavior, infection mechanisms, and the testing of potential treatments. For example, in August 2024, data released by the UK Health Security Agency (UKHSA), a UK-based executive agency, indicated that England recorded 368 measles cases in 2023, representing an almost sevenfold rise from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Consequently, the growing incidence of infectious diseases is fueling the expansion of the organoid kit market.
Companies in the organoid kit market are developing innovative solutions to improve consistency and scalability in organoid studies. One such innovation is rapid aggregate formation, which enables researchers to quickly generate thousands of uniform pluripotent stem cell aggregates in a single day, significantly reducing organoid development time. For instance, in June 2025, Pluristyx Inc., a US-based biotechnology company, introduced its PluriForm Organoid Kit, designed to streamline the creation of pluripotent stem cell aggregates and speed up organoid development. The kit offers a ready-to-use platform that shortens the timeline for generating mature organoids from months to just weeks. It integrates optimized growth media and standardized protocols, ensuring reproducibility across various cell types and supporting high-throughput applications for large-scale disease modeling and drug screening.
In April 2024, Sartorius AG, a Germany-based biotechnology company, formed a partnership with TheWell Bioscience Inc. to advance 3D cell culture and organoid research. This collaboration aims to enhance Sartorius AG’s 3D cell culture solutions by integrating TheWell Bioscience’s specialized hydrogel platforms, which are designed for use in organoid and spheroid research. TheWell Bioscience Inc., a US-based biotechnology company, specializes in 3D cell culture and organoid technology, leveraging advanced hydrogel platforms to support cellular modeling.
Major companies operating in the organoid kit market are STEMCELL Technologies Inc., Bio-Techne Corporation, Takara Bio Inc., American Type Culture Collection (ATCC), ACROBiosystems Inc., MIMETAS B.V., Emulate Inc., CN Bio Innovations Limited, InSCREENeX GmbH, TheWell Bioscience Inc., Prellis Biologics Inc., Crown Bioscience International, AMS Biotechnology (Europe) Limited (AMSBIO), Xylyx Bio Inc., Organovo Holdings Inc., HUB Organoids Holding B.V., Cellesce Ltd., DefiniGEN Ltd., OcellO B.V., AlveoliX AG, VitroLabs Inc.
North America was the largest region in the organoid kit market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organoid kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the organoid kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the organoid kit market by raising the costs of imported reagents, culture media, and laboratory instruments. Research institutes, pharmaceutical companies, and biotech firms in Europe and Asia-Pacific are most affected. Segments such as brain and liver organoid kits face higher import costs. Positive outcomes include boosting domestic production and fostering innovation in locally produced organoid kits, reducing long-term dependency on imports.
The organoid kit market research report is one of a series of new reports that provides organoid kit market statistics, including organoid kit industry global market size, regional shares, competitors with a organoid kit market share, detailed organoid kit market segments, market trends and opportunities, and any further data you may need to thrive in the organoid kit industry. This organoid kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Organoid kits are specialized laboratory toolsets designed to culture and grow miniaturized, three-dimensional organ-like structures from stem cells. These kits provide essential reagents, growth factors, and protocols to replicate organ development and function in vitro. They are widely applied in biomedical research, drug discovery, and disease modeling.
The primary types of organoid kits are brain organoids, kidney organoids, intestinal organoids, liver organoids, and others. Brain organoids are three-dimensional, miniaturized models of the human brain developed for research and therapeutic applications. Technologies used include 3D cell culture, microfluidics, bioprinting, and electrospinning. Source types include human-derived, animal-derived, and cell line-derived organoids. Applications span drug discovery and development, disease modeling, personalized medicine, regenerative medicine, and others. Key end users include research institutes, pharmaceutical companies, contract research organizations, and biotech companies.
The organoid kit market consists of revenues earned by entities by providing services such as organoid co-culture kits, organoid-on-a-chip integration services, and organoid toxicology testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The organoid kit market also includes sales of organoid biobanking kits, organoid functional assay kits, and organoid gene editing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Organoid Kit Market Characteristics
3. Organoid Kit Market Supply Chain Analysis
4. Global Organoid Kit Market Trends and Strategies
5. Organoid Kit Market Analysis of End Use Industries
7. Global Organoid Kit Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Organoid Kit Total Addressable Market (TAM) Analysis for the Market
9. Organoid Kit Market Segmentation
10. Organoid Kit Market Regional and Country Analysis
11. Asia-Pacific Organoid Kit Market
12. China Organoid Kit Market
13. India Organoid Kit Market
14. Japan Organoid Kit Market
15. Australia Organoid Kit Market
16. Indonesia Organoid Kit Market
17. South Korea Organoid Kit Market
18. Taiwan Organoid Kit Market
19. South East Asia Organoid Kit Market
20. Western Europe Organoid Kit Market
21. UK Organoid Kit Market
22. Germany Organoid Kit Market
23. France Organoid Kit Market
24. Italy Organoid Kit Market
25. Spain Organoid Kit Market
26. Eastern Europe Organoid Kit Market
27. Russia Organoid Kit Market
28. North America Organoid Kit Market
29. USA Organoid Kit Market
30. Canada Organoid Kit Market
31. South America Organoid Kit Market
32. Brazil Organoid Kit Market
33. Middle East Organoid Kit Market
34. Africa Organoid Kit Market
36. Organoid Kit Market Competitive Landscape and Company Profiles
37. Organoid Kit Market Other Major and Innovative Companies
40. Organoid Kit Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Organoid Kit Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses organoid kit market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for organoid kit? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The organoid kit market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Brain Organoids; Kidney Organoids; Intestinal Organoids; Liver Organoids; Other Organoid Types2) By Technology: 3D Cell Culture Technology; Microfluidics Technology
3) By Source: Human-Derived Organoids; Animal-Derived Organoids; Cell Line-Derived Organoids
4) By Application: Drug Discovery and Development; Disease Modeling; Personalized Medicine; Other Applications
5) By End-User: Research Institutes; Pharmaceutical Companies; Contract Research Organizations; Biotech Companies
Subsegments:
1) By Brain Organoids: Cerebral Organoids; Midbrain Organoids; Retinal Organoids2) By Kidney Organoids: Nephron Organoids; Collecting Duct Organoids; Glomerular Organoids
3) By Intestinal Organoids: Small Intestine Organoids; Colon Organoids; Gastric Organoids
4) By Liver Organoids: Hepatic Organoids; Cholangiocyte Organoids; Biliary Organoids
5) By Other Organoid Types: Pancreatic Organoids; Lung Organoids; Heart Organoids; Tumor Organoids
Companies Mentioned: STEMCELL Technologies Inc.; Bio-Techne Corporation; Takara Bio Inc.; American Type Culture Collection (ATCC); ACROBiosystems Inc.; MIMETAS B.V.; Emulate Inc.; CN Bio Innovations Limited; InSCREENeX GmbH; TheWell Bioscience Inc.; Prellis Biologics Inc.; Crown Bioscience International; AMS Biotechnology (Europe) Limited (AMSBIO); Xylyx Bio Inc.; Organovo Holdings Inc.; HUB Organoids Holding B.V.; Cellesce Ltd.; DefiniGEN Ltd.; OcellO B.V.; AlveoliX AG; VitroLabs Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Organoid Kit market report include:- STEMCELL Technologies Inc.
- Bio-Techne Corporation
- Takara Bio Inc.
- American Type Culture Collection (ATCC)
- ACROBiosystems Inc.
- MIMETAS B.V.
- Emulate Inc.
- CN Bio Innovations Limited
- InSCREENeX GmbH
- TheWell Bioscience Inc.
- Prellis Biologics Inc.
- Crown Bioscience International
- AMS Biotechnology (Europe) Limited (AMSBIO)
- Xylyx Bio Inc.
- Organovo Holdings Inc.
- HUB Organoids Holding B.V.
- Cellesce Ltd.
- DefiniGEN Ltd.
- OcellO B.V.
- AlveoliX AG
- VitroLabs Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.52 Billion |
| Forecasted Market Value ( USD | $ 2.75 Billion |
| Compound Annual Growth Rate | 15.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
